These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8932448)

  • 21. Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations.
    Baumgartner R; Eitzlmayr A; Matsko N; Tetyczka C; Khinast J; Roblegg E
    Int J Pharm; 2014 Dec; 477(1-2):1-11. PubMed ID: 25304093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
    Bhakay A; Azad M; Bilgili E; Dave R
    Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
    Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
    Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds.
    Komasaka T; Fujimura H; Tagawa T; Sugiyama A; Kitano Y
    Chem Pharm Bull (Tokyo); 2014; 62(11):1073-82. PubMed ID: 25366311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P; Liu X; Fahr A
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1481-500. PubMed ID: 21895540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.
    Li M; Alvarez P; Orbe P; Bilgili E
    AAPS PharmSciTech; 2018 May; 19(4):1789-1801. PubMed ID: 29603084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
    Yan HM; Song J; Zhang ZH; Jia XB
    Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique.
    Ye Y; Zhang X; Zhang T; Wang H; Wu B
    Drug Dev Ind Pharm; 2015; 41(9):1416-24. PubMed ID: 25204767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanosizing: a formulation approach for poorly-water-soluble compounds.
    Merisko-Liversidge E; Liversidge GG; Cooper ER
    Eur J Pharm Sci; 2003 Feb; 18(2):113-20. PubMed ID: 12594003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
    Niwa T; Danjo K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):272-81. PubMed ID: 23907001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical nanocrystals: production by wet milling and applications.
    Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
    Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
    Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
    Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate.
    Yamaguchi M; Yasueda S; Isowaki A; Yamamoto M; Kimura M; Inada K; Ohtori A
    Int J Pharm; 2005 Sep; 301(1-2):121-8. PubMed ID: 16023810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: The influence of mannitol as a co-milling agent.
    Malamatari M; Somavarapu S; Kachrimanis K; Bloxham M; Taylor KMG; Buckton G
    Int J Pharm; 2016 Nov; 514(1):200-211. PubMed ID: 27863663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds.
    Andersson SBE; Alvebratt C; Bergström CAS
    Pharm Res; 2017 Sep; 34(9):1805-1816. PubMed ID: 28620887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shedding a light on the physical stability of suspensions micronised with intensified vibratory milling; A trend observed with decreasing particle size as a function of time.
    De Cleyn E; Holm R; Van den Mooter G
    Int J Pharm; 2021 Jun; 603():120687. PubMed ID: 33965542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
    Ghosh I; Schenck D; Bose S; Ruegger C
    Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.